Hematopoietic Stem Cell Transplant (HSCT Treatment) for Multiple Sclerosis at Artemis Super Speciality Hospital, Gurgaon India

Multiple Sclerosis is a potentially disabling disease that disrupts the flow of information in the central nervous system (brain and spinal cord) the disease can cause permanent damage or deterioration of the nerves. Multiple Sclerosis is a potentially disabling disease that disrupts the flow of information in the central nervous system (brain and spinal cord)

HSCT STOPS MS – ​How does HSCT Treatment work ?

Multiple Sclerosis is a potentially disabling disease that disrupts the flow of information in the central nervous system (brain and spinal cord) the disease can cause permanent damage or deterioration of the nerves. HSCT or Hematopoietic Stem Cell Transplant is a scientifically proven treatment currently available that stops disease progression of Multiple Sclerosis. HSCT involves

HSCT Treatment at Artemis Hospital, Gurgaon India

Artemis Hospital India is a Joint Commission, USA Accredited World Class Facility that pioneered HSCT treatment for MS in 2016 and has treated the largest numbers of Multiple Sclerosis(MS) patients from around the world. 1) HSCT Non-myeloablative protocol at our hospital in India is a combo of Autologus Stem Cells + Chemotherapy with complete patient stay

New treatment can ‘halt’ multiple sclerosis, says study

New treatment can ‘halt’ multiple sclerosis, says study. Aggressive chemotherapy followed by a stem cell transplant can halt the progression of multiple sclerosis , a small study has suggested. The research, published in The Lancet, looked at 24 patients aged between 18 and 50 from three hospitals in Canada. For 23 patients the treatment greatly

Cancer treatment for MS patients gives ‘remarkable’ results

Cancer treatment for MS patients gives ‘remarkable’ results UK doctors in Sheffield say patients with multiple sclerosis are showing “remarkable” improvements after receiving a treatment usually used for cancer. About 20 patients have received bone marrow transplants using their own stem cells. Some patients who were paralysed have been able to walk again. Prof Basil

Intense Stem Cell Therapy Shows Promise as MS Treatment

Intense Stem Cell Therapy Shows Promise as MS Treatment A therapy known as HSCT performed well in a clinical trial, but experts caution the treatment might not be for everybody. HSCT IndiaStem cells may be an important pathway for the successful treatment of multiple sclerosis, although it can be a long and painful road getting

Australian AHSCT Trial Results Released

Australian AHSCT Trial Results Released. - The results of an observational study of 35 people with relapsing-remitting and secondary progressive MS who received the treatment in Sydney have just been released. - Autologous haematopoietic stem cell therapy (AHSCT) uses a combination of chemotherapy and reinfusion of blood stem cells to rebuild and reset the immune

Stem Cell Transplants Improve on Current MS Treatments

Stem Cell Transplants Improve on Current MS Treatments. A one-time stem cell transplantation treatment for multiple sclerosis showed improvements over the current therapies, according to a preliminary trial published in the Journal of the American Medical Association (JAMA). The process, called hematopoietic stem cell transplantation (HSCT), temporarily shuts down and reboots patients’ immune systems, allowing

Stem cell transplantation effectively reverses multiple sclerosis in some patients

Stem cell transplantation effectively reverses multiple sclerosis in some patients Preliminary results reported on 15 January in JAMA suggest hematopoietic stem cell transplantation (HSCT) may be more effective than traditional therapies for treating the most common form of multiple sclerosis (1). Multiple sclerosis is a potentially disabling condition that causes a range of symptoms including

Stem cell therapy for relapsing MS proves effective and safe, study finds

Stem cell therapy for relapsing MS proves effective and safe, study finds (CNN)-An experimental stem cell therapy proved effective and safe in patients with a relapsing form of multiple sclerosis , an autoimmune disease that affects the central nervous system, new research finds. A stem cell transplant using a lower-dose regimen of chemotherapy plus immune

For some multiple sclerosis patients, knocking out the immune system might work better than drugs

For some multiple sclerosis patients, knocking out the immune system might work better than drugs. In multiple sclerosis (MS), a disease that strips away the sheaths that insulate nerve cells, the body’s immune cells come to see the nervous system as an enemy. Some drugs try to slow the disease by keeping immune cells in

Greater Benefits for Relapsing-Remitting MS Found with HSCT Therapy

Greater Benefits for Relapsing-Remitting MS Found with HSCT Therapy Nonmyeloablative hematopoietic stem cell transplantation (HSCT) was associated with prolonged time to disease progression when compared to disease-modifying therapies (DMT) for patients with relapsing-remitting multiple sclerosis (RRMS), according to results published in Journal of the American Medical Association (JAMA). Nonmyeloablative hematopoietic stem cell transplantation (HSCT) was

Stem Cell Transplant Effective for Select MS Patients

Stem Cell Transplant Effective for Select MS Patients Lesion load, disability improved for relapsing patients with highly active MS. Stem cell transplantation was more effective than disease-modifying therapy (DMT) for patients with highly active relapsing-remitting multiple sclerosis (MS), a randomized clinical trial showed. Over a median follow-up of 2 years, only three of 55 patients

Intense Stem Cell Therapy – a Possible Treatment for Multiple Sclerosis

Intense Stem Cell Therapy – a Possible Treatment for Multiple Sclerosis A new Intense Stem Cell Therapy known as HSCT has shown promising results during a clinical trial. However, experts give words of caution, saying that it might not work for everyone. Stem cells might prove to be an important breakthrough for the treatment of

Progress for Stem Cell Transplant in MS

Progress for Stem Cell Transplant in MS A small, preliminary study in JAMA has found that hematopoetic stem cell transplant (HSCT) may be more effective than disease modifying drugs in patients with highly active relapsing-remitting multiple sclerosis (MS).1 The study is the first randomized trial of HSCT in relapsing-remitting MS. Findings were published online on

Stem Cell Transplant Enabled This Wheelchair-bound MS Patient To Walk Again

Stem Cell Transplant Enabled This Wheelchair-bound MS Patient To Walk Again A small, preliminary study in JAMA has found that hematopoetic stem cell transplant (HSCT) may be more effective than disease modifying drugs in patients with highly active relapsing-remitting multiple sclerosis (MS).1 The study is the first randomized trial of HSCT in relapsing-remitting MS. Findings

Linda onderging stamceltherapie in India om MS te stoppen: ‘Ik heb goede hoop dat het nu beter gaat’

Linda onderging stamceltherapie in India om MS te stoppen: ‘Ik heb goede hoop dat het nu beter gaat’ MS-patiënte Linda Liebregt (36) is een week terug uit India. Daar onderging ze een risicovolle stamceltherapie in de hoop de verwoestende ziekte stop te zetten. “Mijn woonkamer is mijn leefruimte, daar zit ik in quarantaine. Maar dat